Left-sided hernia, n (%) |
17 (77) |
59 (92) |
0.060 |
Abnormal karyotype, n/N (%) |
1/17 (6) |
3/53 (6) |
1 |
LHR |
1.5 ± 0.1 |
1.8 ± 0.1 |
0.135 |
MRI lung volume, o/e |
0.37 ± 0.02 |
0.43 ± 0.01 |
0.113 |
Intrathoracic liver, n/N (%) |
8/15 (53) |
11/53 (21) |
0.017 |
Inborn, n (%) |
19 (86) |
53 (83) |
0.956 |
Gestational age (wks) |
37.8 ± 0.6 |
39.3 ± 0.2 |
0.004 |
Birth weight (g) |
2990 ± 180 |
3179 ± 64 |
0.213 |
ECMO, n |
0 |
0 |
- |
Prosthetic patch repair, n/N (%) |
3/22 (14) |
8/58 (14) |
1 |
Length of ICU stay (d) |
31.9 ± 6.8 |
20.3 ± 2.5 |
0.049 |
Length of hospital stay (d) |
59.2 ± 10.9 |
35.8 ± 3.7 |
0.010 |
Home oxygen therapy, n (%) |
4 (18) |
1 (2) |
0.019 |
Home enteral nutrition, n (%) |
6 (27) |
9 (14) |
0.159 |
Pulmonary hypertension at discharge, n/N (%) |
6/22 (27) |
13/63 (21) |
0.520 |
Older siblings at home, n/N (%) |
13/21 (62) |
34/63 (54) |
0.526 |
Day-care attendance |
5/22 (23) |
20/62 (32) |
0.531 |
Passive smoking (%) |
4/20 (20) |
18/61 (30) |
0.587 |
Familial atopy (%) |
13 (59) |
24 (37) |
0.078 |
Eczema (%) |
9/20 (45) |
10/61 (16) |
0.012 |
Palivizumab prevention (%) |
14 (64) |
39 (61) |
0.822 |